Search results
Masimo Corp (MASI) Posts Mixed Year-End Results Amidst Healthcare and Non-Healthcare Segment ...
GuruFocus.com via Yahoo Finance· 3 months agoConsolidated Revenue: $2,048.1 million for the full year, with Q4 contributing $548.9 million....
This Analyst Believes Precigen's Non-Healthcare Divesture Removes Financial Overhang
Benzinga via Yahoo Finance· 2 years agoYesterday, Precigen Inc (NASDAQ: PGEN) agreed to sell its non-healthcare subsidiary to URUS. HC...
Masimo (MASI) Q2 Earnings Lag Estimates, Margins Rise
Zacks via Yahoo Finance· 10 months agoMasimo Corporation MASI delivered adjusted earnings per share (EPS) of 62 cents in the second...
Masimo Corp (MASI) Q1 2024 Earnings: Surpasses Revenue Estimates, Aligns with EPS Projections
GuruFocus.com via Yahoo Finance· 1 month agoRevenue: Reported $492.8 million, surpassing estimates of $487.55 million. Net Income: GAAP net...
Masimo (MASI) Posts Preliminary Q4 Results, Issues FY24 View
Zacks via Yahoo Finance· 5 months agoMasimo Corporation MASI announced preliminary financial results for fourth-quarter 2023 on Jan 10....
Why Is Masimo (MASI) Up 0.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Masimo (MASI). Shares have added about...
Masimo (MASI) Plans Consumer Business Spin-Off to Drive Growth
Zacks via Yahoo Finance· 2 months agoMasimo (MASI) is evaluating a proposed separation of its consumer audio and consumer health product...
If You Invested $1000 in Masimo a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 4 months agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
WCMH via Yahoo News· 2 months agoWASHINGTON (AP) — Rarely a day goes without President Joe Biden mentioning insulin prices. He...
Masimo's (MASI) Preliminary Q2 Revenues Dampened by Lower Sales
Zacks via Yahoo Finance· 11 months agoMasimo's (MASI) second-quarter 2023 results are likely to have been dampened by the postponement of...